Lynn A. Tetrault, Director at NEOGENOMICS INC (NEO), sold 13,000 shares at $16.00 ($208K) on 2018-11-19, disclosed to the SEC on 2018-11-21.
Open-market sale of $208k NEO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.97 | 2,000 | $32K | 15.4% |
| 2 | $16.00 | 11,000 | $176K | 84.6% |
| Total | $16.00 avg | 13,000 | $208K | 100% |
| Filing → |
| NEO | SELL | 2026-06-11 | $60K | — | Filing → |
| NEO | BUY | 2025-05-09 | $114K | — | Filing → |
| RYTM | SELL | 2024-09-11 | $2.0M | — | Filing → |